Literature DB >> 10597439

Searching for alcoholism susceptibility genes using Markov chain Monte Carlo methods.

S M Leal1, S C Heath.   

Abstract

Markov chain Monte Carlo (MCMC) methods offer a rapid parametric approach that can test for linkage throughout the entire genome. It has an advantage similar to nonparametric methods in that the model does not have to be completely specified a priori. However, unlike nonparametric methods, there are no limitations on pedigree size and MCMC methods can also handle relatively complex pedigree structures. In addition MCMC methods can be used to carry segregation analysis in order to answer questions on the genetic components of a disease phenotype. Segregation analysis gave evidence for between two and eight alcoholism susceptibility loci, each having a modest effect on the phenotype. MCMC methods were used to map alcoholism loci using the phenotypes ALDX1 (DSM-III-R and Feighner criteria) and ALDX2 (World Health Organization diagnosis ICD-10 criteria). There was mild evidence for quantitative trait loci on chromosomes 2, 10, and 11.

Entities:  

Mesh:

Year:  1999        PMID: 10597439      PMCID: PMC6141008          DOI: 10.1002/gepi.1370170737

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  3 in total

1.  Markov chain Monte Carlo segregation and linkage analysis for oligogenic models.

Authors:  S C Heath
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Effects of misspecifying genetic parameters in lod score analysis.

Authors:  F Clerget-Darpoux; C Bonaïti-Pellié; J Hochez
Journal:  Biometrics       Date:  1986-06       Impact factor: 2.571

3.  Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees.

Authors:  E W Daw; S C Heath; E M Wijsman
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

  3 in total
  1 in total

1.  The Familial Intracranial Aneurysm (FIA) study protocol.

Authors:  Joseph P Broderick; Laura R Sauerbeck; Tatiana Foroud; John Huston; Nathan Pankratz; Irene Meissner; Robert D Brown
Journal:  BMC Med Genet       Date:  2005-04-26       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.